IRIS
PANE, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.011
NA - Nord America 13.439
EU - Europa 9.898
SA - Sud America 2.410
Continente sconosciuto - Info sul continente non disponibili 868
AF - Africa 365
OC - Oceania 17
Totale 41.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.690
SG - Singapore 6.265
RU - Federazione Russa 4.032
CN - Cina 2.619
VN - Vietnam 2.394
IT - Italia 2.331
BR - Brasile 1.872
HK - Hong Kong 1.145
DE - Germania 601
FR - Francia 535
NL - Olanda 448
UA - Ucraina 423
FI - Finlandia 412
BD - Bangladesh 374
CA - Canada 315
IE - Irlanda 303
GB - Regno Unito 288
MX - Messico 263
IN - India 252
JP - Giappone 222
AR - Argentina 149
SE - Svezia 140
KR - Corea 121
EC - Ecuador 104
CO - Colombia 101
IQ - Iraq 95
CI - Costa d'Avorio 93
ZA - Sudafrica 80
PH - Filippine 70
ES - Italia 68
TH - Thailandia 68
PL - Polonia 65
ID - Indonesia 54
TR - Turchia 51
AT - Austria 45
PK - Pakistan 41
CL - Cile 39
BO - Bolivia 35
MA - Marocco 35
TW - Taiwan 35
JM - Giamaica 34
LT - Lituania 34
PE - Perù 32
VE - Venezuela 32
CZ - Repubblica Ceca 28
PY - Paraguay 28
CR - Costa Rica 26
HN - Honduras 26
KE - Kenya 25
UZ - Uzbekistan 24
SA - Arabia Saudita 21
AE - Emirati Arabi Uniti 19
EG - Egitto 19
JO - Giordania 19
BG - Bulgaria 18
NP - Nepal 17
AL - Albania 16
CH - Svizzera 16
UY - Uruguay 16
AZ - Azerbaigian 15
TN - Tunisia 15
BE - Belgio 14
ET - Etiopia 12
TT - Trinidad e Tobago 12
AU - Australia 11
DZ - Algeria 10
GT - Guatemala 10
IL - Israele 10
MY - Malesia 10
PT - Portogallo 10
RS - Serbia 10
DO - Repubblica Dominicana 9
HR - Croazia 9
IR - Iran 9
SN - Senegal 9
LV - Lettonia 8
NI - Nicaragua 8
PA - Panama 8
BB - Barbados 7
GE - Georgia 7
PS - Palestinian Territory 7
HU - Ungheria 6
KZ - Kazakistan 6
LY - Libia 6
RO - Romania 6
SV - El Salvador 6
BH - Bahrain 5
BW - Botswana 5
EE - Estonia 5
KW - Kuwait 5
LB - Libano 5
NG - Nigeria 5
RE - Reunion 5
BS - Bahamas 4
KG - Kirghizistan 4
KH - Cambogia 4
MG - Madagascar 4
MK - Macedonia 4
MU - Mauritius 4
OM - Oman 4
Totale 40.036
Salva come PNG Salva come JPEG
Città #
Singapore 2.853
San Jose 2.298
Hong Kong 1.103
Moscow 1.069
Ashburn 967
Chandler 786
Beijing 677
Ho Chi Minh City 670
Hanoi 509
Hefei 441
Santa Clara 422
Council Bluffs 373
Amsterdam 364
Jacksonville 357
Los Angeles 351
The Dalles 350
Lauterbourg 341
Naples 331
Millbury 313
Princeton 283
Napoli 234
Nanjing 210
New York 200
Boston 197
Tokyo 196
Munich 188
Buffalo 186
São Paulo 177
Des Moines 151
Dallas 139
Wilmington 138
Rome 125
Milan 124
Phoenix 123
Redondo Beach 119
Chicago 118
Haiphong 102
Ottawa 99
Dong Ket 94
Da Nang 91
Seattle 91
Frankfurt am Main 90
Seoul 84
Turku 82
Nanchang 69
Denver 68
Woodbridge 64
London 63
Orem 62
Mexico City 61
Montreal 61
Brooklyn 60
Chennai 60
Atlanta 55
Lawrence 55
Houston 53
Hebei 51
Warsaw 51
Toronto 50
Helsinki 49
Rio de Janeiro 47
Brasília 43
Poplar 42
Jiaxing 41
San Francisco 41
Norwalk 40
Quito 40
Belo Horizonte 39
Nuremberg 39
Tianjin 39
Shenyang 38
Dublin 36
Stockholm 35
Ann Arbor 34
Changsha 33
Bangkok 32
Johannesburg 32
Baghdad 31
Falkenstein 31
Hải Dương 30
Biên Hòa 28
Charlotte 28
Guayaquil 27
Lima 27
Mumbai 27
Kochi 26
Bologna 25
Figino 25
Kingston 25
Washington 25
Bogotá 24
Curitiba 24
Medellín 24
Dhaka 23
Lappeenranta 23
Fortaleza 22
Kunming 22
La Paz 22
Manchester 22
Nairobi 22
Totale 20.382
Salva come PNG Salva come JPEG
Nome #
Leucemia Mieloide Cronica 1.434
Frequenza delle mutazioni c-kit in pazienti affetti da Leucemia mieloide acuta (LAM) caratterizzata da alterazioni del gene del core binding factor (CBF) 453
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study 311
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 231
NANOG: ITS ROLE IN THE TKI RESISTANCE OBSERVED IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA 228
Secondary syphilis mimicking malignancy: A case report and review of literature 221
Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas. 219
Biochimica del pancreas 212
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study 197
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 197
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 191
Ibrutinib as salvage therapy in mantle cell lymphoma with central nervous system involvement in a pretreated unfit patient 189
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma 188
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL 184
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience 182
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21 181
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study 181
Transition index: new original tool to identify subsets overlapping MPN phenotypes. 181
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 181
A Novel Score to Predict Interferon-Alpha Therapy Responsiveness in Patients with Essential Thrombocythemia 176
Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma 175
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 171
Pseudouridine and 1-ribosylpyridin-4-one-3-carboxamide (PCNR) serum concentrations in human immunodeficiency virus type 1-infected patients are independent predictors for AIDS progression 169
Advanced-stage Hodgkin Lymphoma: US/Chest Radiography for Detection of Relapse in Patients in First Complete Remission—A Randomized Trial of Routine Surveillance Imaging Procedures 165
Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma 163
RISPOSTA EMATOLOGICA AL TRATTAMENTO CON LENALIDOMIDE IN UNA PAZIENTE AFFETTA DA TROMBOCITEMIA ESSENZIALE JAK2 V617F-POSITIVA E SINDROME MIELODISPLASTICA ASSOCIATA A DEL(5Q) 161
Eltrombopag for post-transplant cytopenias due to poor graft function 160
Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma 159
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide 158
Reduced regulatory T cells (Treg) in bone marrow preferentially associate with the expansion of cytotoxic T lymphocytes in low risk MDS patients. 158
MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS 157
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial 157
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 156
Ultrasonography-guided core-needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front-line biopsies in a multicenter Italian study 156
[Complete diagnostic work-up provides the rational basis for the most appropriate therapy of myelodysplastic syndromes] 155
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?. 154
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 154
Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1,3-β-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography 154
Myeloma and other monoclonal gammopathies - Clinical SINONASAL EXTRAMEDULLARY PLASMACYTOMA: PROPOSAL OF PROTOCOL OF FOLLOW-UP 154
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 153
Safety and comfort of domestic bortezomib injection in real-life experience 153
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial 152
SPLEEN VOLUME IS THE MOST ACCURATE PARAMETER TO AVOID UNDERSTIMATION OF 25% SPLENOMEGALIC PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA 152
Livelli sierici degli isoenzimi della LDH e della pseudoridina in leucemie e linfomi 151
Prevalence of Chlamydia psittaci, Chlamydia pneumoniae, and Chlamydia trachomatis Determined by Molecular Testing in Ocular Adnexa Lymphoma Specimens 150
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia 149
FLUORESCENT IN SITU HYBRIDIZATION (FISH) ON PERIPHERAL BLOOD AND BONE MARROW SMARS: 120 MINUTES FOR DETECTION OF PML/RARa FUSION GENE 148
Rituximab-containing risk-adapted treatment strategy in nodular lymphocyte predominant hodgkin lymphoma: 7-years follow-up 147
In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression. 147
ALEMTUZUMAB FOR APLASTIC ANEMIA AND RELATED IMMUNE-MEDIATED BONE MARROW FAILURES: LONG-TERM FOLLOW UP OF A PILOT STUDY 147
Acute immune toxicity during anti-thymocyte globulin: That's CARPA! 147
New insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: the role of Shp1 and Shp2 146
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 145
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 145
JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study. 145
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION 145
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support 145
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene 144
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 144
Serum pseudouridine in the diagnosis of acute leukaemias and as a novel prognostic indicator in acute lymphoblastic leukaemia 143
LONG-TERM FOLLOW UP OF ALENTUZUMAB-BASED IMMUNOSUPPRESSION FOR THE TREATMENT OF IMMUNE-MEDIATED BONE MARROW FAILURE SYNDROMES 142
Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease 141
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia 141
Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia. 140
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 140
PEG-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION : A SINGLE-CENTRE EXPERIENCE 139
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease 139
Longitudinal strain of left ventricular basal segments and E/e′ ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: An automated function imaging study 138
Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma 138
Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation. 137
Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib. 137
CLINICAL RELEVANCE IN CHRONIC MYELOID LEUKEMIA OF DELETION AND INSERTION EVENTS IN THE TYROSINE KYNASE DOMAIN OF BCR-ABL 137
Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: A real-life experience 137
Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. 136
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study 135
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies 135
Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate 135
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis. 135
Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel. 135
Correspondence in reference to the previously published Epub manuscript by Peter Hokland et al. 'How I treat advanced Hodgkin lymphoma - a global view'. Br J Haematol. 2020;190:837-50 135
Coesistence of two distinct cell populations (CD56+Tcr gammadelta+ and CD56+ Tcr gammadelta-) in a case of aggressive CD56+ lymphoma/leukemia 134
Excellent outcome of concomitant intensive immunosuppression and eculizumab in aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome. 134
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE 134
Early ultrasonographic finding of septic thrombophlebitis is the main indicator of central venous catheter removal to reduce infection-related mortality in neutropenic patients with bloodstream infection. 133
CIRCULATING MEGAKARYOCYTE-DERIVED CELLS DETECTED BY FLOW CYTOMETRY AS MARKER OF AGGRESSIVE NEOPLASM OF MEGAKARYOCYTIC LINEAGE IN ACUTE MEGAKARYOBLASTIC LEUKEMIA AND ALLIED MALIGNANCIES PRESENTING AS PRIMARY MYELOFIBROSIS 133
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA 133
Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia 133
Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-),derived from a single patient with CD56+ non- Hodgkin's lymphoma. 132
Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience 131
Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective study 130
Cytotoxic T lymphocytes directed to the Preferentially Expressed Antigen of Melanoma (PRAME) target chronic myeloid leukemia. 130
Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses. 130
Clinical pathway for patients with Chronic Myeloid Leukaemia: The Euriclea Project 130
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 129
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone 129
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. 128
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical relation. 128
Amyloid in bone marrow smears of patients affected by multiple myeloma. 128
Sjögren Syndrome in Primary Salivary Gland LymphomaA Systematic Review and Meta-Analysis 128
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules 128
Totale 17.038
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.817
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.829 0 0 22 9 17 63 24 51 303 126 493 721
2022/20232.170 344 104 75 101 270 224 10 220 343 340 94 45
2023/20241.343 58 195 199 66 90 116 14 175 27 24 256 123
2024/20259.390 480 472 27 88 232 381 890 667 1.012 1.080 3.224 837
2025/202618.985 1.989 1.492 1.901 1.628 3.125 734 1.973 1.244 2.309 1.356 722 512
2026/20272.213 592 1.052 569 0 0 0 0 0 0 0 0 0
Totale 41.008